Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantBone Diseases, Developmental, Bone Marrow Failure Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Immunodeficiency Diseases, acute myeloid leukemia, anemia, aplastic anemia, bone disorder, bone marrow disorder, hematologic disorder, hematopoietic and lymphoid system neoplasm, hereditary disease, immune system disorder, immunoproliferative disorder, inborn error of immunity, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, musculoskeletal system disorder, myelodysplastic syndrome, myeloid leukemia, neoplasm, osteochondrodysplasia, osteopetrosis, osteosclerosisActive, not recruitingPhase 1 / Phase 22022-07-12NCT03301168

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bellicum Pharmaceuticals12

10 results · Page 1 of 1

Swipe the table sideways for more columns.